April 11, 2026Blood Research0 citationsOpen Access
Autologous bone marrow transplantation in non-hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study
To assess the impact of different conditioning regimens on survival outcomes in NHL patients undergoing autologous stem cell transplantation (ASCT).
Quasi-experimental study design at a single center
Inclusion of NHL patients undergoing ASCT
Comparison of survival outcomes with and without carboplatin in the EAM regimen
No significant difference in survival outcomes observed with the addition of carboplatin to the EAM regimen
Findings suggest that carboplatin may not enhance survival in this population
Abstract
Our real-world data indicate that the addition of carboplatin to the EAM conditioning regimen does not significantly affect survival outcomes for patients with NHL undergoing ASCT.